NCT04597593View on ClinicalTrials.gov

Association Between Genetic Variant Scores and DOACs (DARES2)

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

October 7, 2020

Primary Completion Date

December 29, 2022

Study Completion Date

December 30, 2022

Conditions

Drug-Related Side Effects and Adverse ReactionsIatrogenic Disorder

Trial Locations (1)

Unknown

SNUBH, Seongnam-si

Sponsors

Lead Sponsor

Cipherome, Inc.

All Listed Sponsors

collaborator

Seoul National University Bundang Hospital

OTHER

lead

Cipherome, Inc.

INDUSTRY

NCT04597593 - Association Between Genetic Variant Scores and DOACs (DARES2) | Biotech Hunter | Biotech Hunter